HMMJ:CA:TSX-Global X Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 11.04

Change

0.00 (0.00)%

Market Cap

CAD 0.08B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.07 (-0.19%)

CAD 2.48B
ZWU:CA BMO Covered Call Utilities ETF

+0.02 (+0.19%)

CAD 1.81B
TXF:CA First Asset Tech Giants Covere..

-0.05 (-0.23%)

CAD 0.64B
XIT:CA iShares S&P/TSX Capped Informa..

+0.07 (+0.14%)

CAD 0.61B
XHC:CA iShares Global Healthcare (CAD..

-0.01 (-0.01%)

CAD 0.60B
HTA:CA Tech Achievers Growth & Income..

-0.03 (-0.16%)

CAD 0.57B
ZUT:CA BMO Equal Weight Utilities Ind..

N/A

CAD 0.43B
CWW:CA iShares Global Water Common Cl..

-0.21 (-0.35%)

CAD 0.35B
HHL:CA Harvest Healthcare Leaders Inc..

+0.04 (+0.48%)

CAD 0.33B
COW:CA iShares Global Agriculture Com..

-0.06 (-0.09%)

CAD 0.30B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.84% 100% F 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.84% 100% F 87% B+
Trailing 12 Months  
Capital Gain 8.98% 47% F 61% D-
Dividend Return 1.88% 60% D- 33% F
Total Return 10.86% 50% F 60% D-
Trailing 5 Years  
Capital Gain -73.85% 6% D- 6% D-
Dividend Return 4.82% 38% F 20% F
Total Return -69.03% 6% D- 7% C-
Average Annual (5 Year Horizon)  
Capital Gain -10.21% 6% D- 7% C-
Dividend Return -7.83% 6% D- 7% C-
Total Return 2.39% 66% D+ 63% D
Risk Return Profile  
Volatility (Standard Deviation) 42.75% 9% A- 21% F
Risk Adjusted Return -18.31% 9% A- 23% F
Market Capitalization 0.08B 51% F 34% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.